Earnings History Data for IMARA Inc. (IMRA) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

IMARA Inc.

Imara Inc. is a biopharmaceutical company. It engages in developing and commercializing novel therapeutics to treat patients suffering from rare inherited genetic disorders of haemoglobin. The company's product pipeline consists of IMR-687, which are in clinical stage. Imara Inc. is based in Boston, Massachusetts.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
15-03-2022	PM	7:00 AM ET (Mar 15)	IMRA	IMARA	41.00	-0.53	-0.79	0.00	Imara GAAP EPS of -$2.37 beats by $0.21 [3/15/2022 7:05 AM]	1.73	0.03 (1.76%)	1.47	0.03 (2.08%)	1.10 - 12.95	353,634	263,136	0
Imara GAAP EPS of -$2.37 beats by $0.21 [3/15/2022 7:05 AM] Imara Reports Full Year 2021 Financial Results and Business Highlights [Mar-15-22 07:00AM]
09-11-2021	PM	7:00 AM ET (Nov 9)	IMRA	IMARA	102.00	-0.55	-0.91	0.00	Imara EPS beats by $0.05 [11/9/2021 7:12 AM]	3.93	0.22 (5.93%)	0.0	0.0 (0.00%)	3.37 - 29.91	107,803	100,000	0
Imara EPS beats by $0.05 [11/9/2021 7:12 AM] Imara to Report Data Demonstrating the Potential of Tovinontrine (IMR-687) for the Treatment of Heart Failure with Preserved Ejection Fraction (HFpEF) [Nov-08-21 07:00AM] Imara Reports Third Quarter 2021 Financial Results and Business Highlights [Nov-09-21 07:00AM]
06-08-2021	PM	7:00 AM ET (Aug 6)	IMRA	IMARA Inc.	155.52	-0.74	1.00	-0.59	Imara EPS beats by $0.03 [8/6/2021 7:08 AM]	5.79	-0.09 (-1.53%)	5.88	0.0 (0.00%)	5.20 - 36.00	190,081	420,000	2,899
Imara EPS beats by $0.03 [8/6/2021 7:08 AM] Imara Announces Completion of Patient Enrollment in Ardent Phase 2b Clinical Trial of IMR-687 (tovinontrine) for Sickle Cell Disease [Aug-05-21 07:15AM] Imara Reports Second Quarter 2021 Financial Results and Business Highlights [Aug-06-21 07:00AM]
11-05-2021	PM	7:00 AM ET (May 11)	IMRA	IMARA Inc.	127.42	-0.58	-0.83	-4.31	Imara EPS beats by $0.25 [5/11/2021 7:16 AM]	7.46	0.51 (7.34%)	6.70	-0.25 (-3.64%)	6.61 - 62.71	124,975	100,000	2,608
Imara EPS beats by $0.25 [5/11/2021 7:16 AM] Imara Inc to Host Earnings Call [May-11-21 06:30AM] Imara Reports First Quarter 2021 Financial Results and Business Highlights [May-11-21 07:00AM]
05-03-2021	PM	7:00 AM ET (Mar 5)	IMRA	IMARA Inc.	233.78	-1.09	-0.84	0.00	Imara EPS misses by $0.27; outlook [3/5/2021 7:04 AM]	10.02	-2.29 (-18.60%)	10.75	-1.56 (-12.67%)	8.49 - 62.71	523,870	81,315	13,724
Imara EPS misses by $0.27; outlook [3/5/2021 7:04 AM] Imara shares fall after FY results, 2021 forecast [3/5/2021 10:00 AM] SIFY, WTI, OPEN and EVFM among notable midday movers [3/5/2021 12:36 PM] Imara Reports Full Year 2020 Financial Results and Business Highlights [Mar-05-21 07:00AM] Imara Inc to Host Earnings Call [Mar-05-21 06:30AM]
05-11-2020	PM		IMRA	IMARA Inc.	288.11	-0.72	-0.83	0.00	Imara EPS in-line [11/5/2020 7:27 AM]	16.30	-0.35 (-2.10%)	0.0	0.0 (0.00%)	13.40 - 62.71	16,375	12,149	0

14-08-2020	PM	7:00 AM ET (Aug 14)	IMRA	IMARA Inc.	345.78	-0.59	-0.61	0.00	Imara EPS misses by $0.04 [8/14/2020 7:09 AM]	20.55	0.34 (1.68%)	21.00	0.79 (3.91%)	13.40 - 62.71	8,766	13,143	102